Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT for Amarin Corporation

Related AMRN
Week Concludes With S&P 500 Below 2,000; Dow Below 17,000
Dow Falls Over 100 Points; Ulta Salon Shares Jump After Earnings Report

In a company note published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Amarin Corporation (NASDAQ: AMRN) and raised its price target from $24.00 to $26.00.

Jefferies & Company went on to say “Yesterday, the patent office (PTO) posted unexpected positive office actions on three key patent applications based on MARINE: the core ‘889 application and two continuation applications ‘408 and '145. We believe these actions should lead to near-term issuance of these patents, which could provide AMR101 protection through 2030. We remain bullish on near-term approval of AMR101.”

Amarin Corporation closed yesterday at $13.16.

Latest Ratings for AMRN

DateFirmActionFromTo
May 2014CitigroupDowngradesBuyNeutral
Feb 2014Aegis CapitalMaintainsHold
Jan 2014MKM PartnersDowngradesBuyNeutral

View More Analyst Ratings for AMRN
View the Latest Analyst Ratings

Posted-In: Jefferies & Company Inc.Analyst Color Price Target Reiteration Analyst Ratings

 

Related Articles (AMRN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters